Skip to evidence report

MAC.MDM.complement_resolving: Studies — page 4

How association tiers are defined — cell–trait and gene–trait

SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.

Cell–trait tiers

Cell–trait links
Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
Required for Specific or Relevant
The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
Specific (Tier 1)
Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
Relevant (Tier 2)
Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
Interpretation and report values
CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
Meta traits and individual traits
Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.

Gene–trait priorities (variant–tCRE–gene evidence)

Variant–tCRE–gene links
Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
Required genetic support
The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
Required cellular support
The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
High priority
Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
Medium priority
Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
Same-record evidence and aggregation
Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
Limits of interpretation
A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.

State · 1,931 full-atlas cells · all tissues.

Marker genes and cell annotation · Open this population in Cell Browser →

ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.

Rows 3,001–4,000 of 12,313; ranked by score descending. Equal values use name/identifier order.

Studies ranked for MAC.MDM.complement_resolving
#Trait / studyIndividual trait IDMean IC score
3001INPP5J levelsGCST904696184.91
3002Bone marrow fat fraction of lumbar vertebra 2GCST906523874.91
3003lymphocyte (absolute count, minimum, inv-norm transformed)GCST904754294.91
3004KLK8/NECTIN4 ratioGCST903152584.90
3005DAB2/LYN ratioGCST903143654.90
3006WAS levelsGCST904710714.90
3007BA-exvivo rh area BA3aGCST900032234.90
3008Bone density (confirmatory factor analysis Factor 19)GCST903093534.90
3009HippSubfield rh volume presubiculum-bodyGCST900026974.89
3010Cholesterol in Large VLDLGCST904981234.89
3011Free Cholesterol to Total Lipids in Small LDL percentageGCST904996354.89
3012Principal component-derived dietary pattern 33GCST901330384.88
3013PEAR1/PECAM1 ratioGCST903156414.88
3014Shoulder lesionsFING000013034.88
3015Parental longevity (combined parental attained age, Martingale residuals)GCST0066974.88
3016PRAP1 levelsGCST904703124.88
3017SELPLG levelsGCST904705684.88
3018Substance dependenceGCST900187044.87
3019Saturated fatty acids to total fatty acids percentageGCST905026844.87
3020rfMRI amplitudes (ICA100 node 45)GCST900046334.87
3021Eosinophil countGCST900259874.87
3022CDNF levelsGCST904686864.87
3023Extrapyramidal and movement disordersFING000005274.87
3024MB levelsGCST904698694.87
3025Pregnenolone sulfate levelsGCST901998734.86
3026Cholesteryl Esters in Small VLDLGCST904997864.86
3027CD1C/CD207 ratioGCST903137454.86
3028Omega-3 fatty acids to Omega-6 fatty acids ratioGCST905020684.86
3029EFNA4/TNFRSF9 ratioGCST903146064.85
3030ALDH1A1/SORD ratioGCST903132484.85
3031Cheese consumptionGCST901330004.85
3032Shoulder lesions | Other soft tissue disordersUKBB000007694.85
3033Primary biliary cholangitisGCST0031294.85
3034ANGPT1 levelsGCST904683004.84
3035NUDT5/SERPINB1 ratioGCST903155814.84
3036Left-hemisphere salience/ventral attention network to hippocampus white-matter structural connectivityGCST903027234.83
3037Lysoalkylphosphatidylcholine (O-24:1) levelsGCST900248134.83
3038SGSH levelsGCST904706154.83
3039F9/FURIN ratioGCST903147474.83
3040Plasma X-24544 levels in chronic kidney diseaseGCST902667574.83
3041HippSubfield lh volume presubiculum-headGCST900026734.83
3042Acylcarnitine (18:2) levelsGCST900246234.82
3043Cerebrospinal fluid unidentified metabolite levels (HILIC Metabolomics ID: 3.04_132.06)GCST902915824.82
3044LDL direct, adjusted by medication | Lipid or lipoprotein measurementUKBB000003884.82
3045SCGB1A1 levelsGCST904705404.82
3046IDP dMRI ProbtrackX MD fmiGCST900042304.80
3047CCL2 levelsGCST904685814.80
3048VSTM2L levelsGCST904710574.80
3049DTI autoptx L2 unc r tractGCST903851924.80
3050SMOC2 levelsGCST904706834.78
3051TNFRSF1B levelsGCST904709114.78
3052ACE2/GGT1 ratioGCST903131534.78
3053CALCOCO1/IRAG2 ratioGCST903136044.78
3054Alzheimer's disease (MTAG)GCST904490604.77
3055Total phospholipid levels in lipoprotein particlesGCST905001104.77
3056IDP T1 SIENAX brain-unnormalised volumeGCST900024354.77
3057aparc-DKTatlas lh volume supramarginalGCST900028914.77
3058C4BPB levelsGCST904684994.77
3059Clonal haematopoiesis of indeterminate potential (TET2 mutation)GCST901652814.77
3060FCER2/TNFRSF9 ratioGCST903147914.77
3061CHI3L1/HSPG2 ratioGCST903140434.76
3062Diacylglycerol (14:0_18:2) levelsGCST900247054.76
3063Operation code - cholecystectomy/gall bladder removal | OperationsUKBB000005544.75
3064XXYLT1 levelsGCST902433704.75
3065Myocardial fractal dimension (slice 7)GCST900002934.75
3066Omega-6 fatty acid levelsGCST905021014.75
3067ENO2/TACC3 ratioGCST903146704.74
3068BA-exvivo rh area MTGCST900032324.74
3069F11R/GP1BA ratioGCST903147224.74
3070CD7 levelsGCST904686494.74
3071Atopic/contact dermatitis due to other or unspecified (PheCode 939)GCST904762894.73
3072Schizophrenia or delusion (more control exclusions)FING000012784.73
3073TNFRSF11A levelsGCST904709024.73
3074OGFR levelsGCST904701184.73
3075SBSN levelsGCST904705314.73
3076Mean platelet volumeGCST900023954.73
3077Linoleic acid to total fatty acids percentageGCST904983284.73
3078NBL1/NECTIN4 ratioGCST903155144.72
3079Epstein-Barr virus ZEBRA antibody levelsGCST900069014.72
30801-(1-enyl-palmitoyl)-GPC (p-16:0) levelsGCST901998994.72
3081aparc-DKTatlas lh volume parsopercularisGCST900028784.72
3082TPMT levelsGCST904709454.72
3083Free thyroxine levels within normal range in pregnancyGCST904351964.72
3084Depression | Mental distressUKBB000001654.72
3085Aniseed likingGCST900946894.72
3086ADIPOQ levelsGCST902930864.71
3087Polyunsaturated fatty acids to total fatty acids percentageGCST905021734.71
3088CTSF/SMPDL3A ratioGCST903143164.71
3089aparc-DKTatlas rh area parsopercularisGCST900032814.71
3090CXCL5/SPARC ratioGCST903143554.71
3091ANGPT2 levelsGCST904683014.70
3092TOR1AIP1 levelsGCST904709354.70
3093CD20 on IgD- CD38- B cellGCST900017554.70
3094LRCH4 levelsGCST904697914.70
3095DTI TBSS FA Posterior corona radiata RGCST903844064.69
3096REG4/SPINK4 ratioGCST903157664.69
3097Cholesteryl esters to total lipids ratio in small HDLGCST900929474.69
3098HS6ST1 levelsGCST904694794.69
3099CD69/TIA1 ratioGCST903138884.68
3100Omega-3 fatty acids to Omega-6 fatty acids ratioGCST905023984.68
3101VAMP5 levelsGCST904710244.68
3102GSTA3 levelsGCST904694124.68
3103Chronic hepatitis B infectionGCST900185844.68
3104Diacylglycerol_44:6_[M+H-H2O]1+ levelsGCST900602454.67
3105ThalamNuclei lh volume CMGCST900027184.67
3106F2R/PDGFB ratioGCST903147334.67
3107Hippocampal subfield right CA1 volume (head)GCST902679614.67
3108Left-hemisphere visual network to left-hemisphere salience/ventral attention network white-matter structural connectivityGCST903026514.67
3109APOM/MCAM ratioGCST903133154.66
3110T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 22)GCST903208414.66
3111X-12411 levelsGCST902004924.66
3112CDH2 levelsGCST904686734.66
3113DLL4 levelsGCST904690054.65
3114NCK2/VASH1 ratioGCST903155264.65
3115Lymphocyte percentage | Blood countUKBB000004124.65
3116HNRNPK/USP8 ratioGCST903150704.64
3117Clonal hematopoiesis (overall)GCST904353534.64
3118EDAR/SNAP23 ratioGCST903145874.64
3119IDP dMRI ProbtrackX ICVF cgh rGCST900043824.64
3120METAP2/USP8 ratioGCST903154344.63
3121ENO2/TXNDC5 ratioGCST903146714.63
3122CDH1/CST3 ratioGCST903139464.63
3123Linoleic acid to total fatty acids percentageGCST905020234.63
3124BCAM levelsGCST904684254.63
3125RTN4R levelsGCST904705084.62
3126Triglycerides to total lipids ratio in small VLDLGCST900929794.62
3127PHLDB1 levelsGCST904702254.62
3128Platelet countGCST900024024.62
3129Platelet count | Blood countUKBB000006464.61
3130Myocardial fractal dimension (slice 2)GCST900002884.61
3131IDP T1 SIENAX brain-normalised volumeGCST900024344.60
3132Triglycerides in large LDL (UKB data field 23536)GCST902696334.60
3133CDH6/NTRK2 ratioGCST903139624.59
3134Deep venous thrombosisGCST904681224.59
3135CXCL11/ITGB1BP2 ratioGCST903143354.59
3136Cooked vegetable intake | DietUKBB000001474.58
3137CD55/CHI3L1 ratioGCST903138454.58
3138SMOC2 levelsGCST900600594.58
3139Docosahexaenoic acid to total fatty acids percentage (UKB data field 23457)GCST902695544.58
3140IDP T1 FAST ROIs R cerebellum VIGCST900025684.58
3141ITM2A levelsGCST904696534.57
3142SLAMF1 levelsGCST902748354.57
3143FGF19 levelsGCST904692204.57
31441-(1-enyl-palmitoyl)-2-linoleoyl-GPE (p-16:0/18:2) levelsGCST902000754.56
3145Principal component-derived dietary pattern 8GCST901330134.56
3146FCN2 levelsGCST904692044.55
3147Polyunsaturated fatty acids to total fatty acids percentageGCST905026494.55
3148CD69/SNAP23 ratioGCST903138864.55
3149F9/FETUB ratioGCST903147464.55
3150DTI autoptx L3 fmi tractGCST903852044.55
3151FKBP5/MITD1 ratioGCST903148444.54
3152CD99L2 levelsGCST904686574.54
3153EDAR/IRAK4 ratioGCST903145794.53
3154Cholesteryl esters to total lipids ratio in chylomicrons and extremely large VLDLGCST900930434.53
3155Malignant neoplasm of oropharynx, excluding all cancers (controls excluding all cancers)FING000007684.53
3156IL1R1 levelsGCST904695714.53
3157FABP5/PPCDC ratioGCST903147634.53
3158wg lh intensity-contrast insulaGCST900038264.53
3159IDP dMRI TBSS ICVF Anterior limb of internal capsule LGCST900043444.52
3160SERPINB8 levelsGCST904705924.52
3161LDLR/MEGF9 ratioGCST903153104.52
3162All pneumoniaeFING000000654.51
3163DKKL1 levelsGCST904690004.51
3164Unspecified osteomyelitis (PheCode 710.19)GCST904762244.51
3165Multi-trait sum scoreGCST902701194.51
3166CNST/PRKAR1A ratioGCST903141614.50
3167FABP2 levelsGCST904691744.49
3168MMP8/PGLYRP1 ratioGCST903154654.49
3169CEBPB levelsGCST904687004.49
31701-stearoyl-2-oleoyl-GPS (18:0/18:1) levelsGCST901996524.49
3171CD84/DAG1 ratioGCST903139104.49
3172EGFR/FAP ratioGCST903146134.49
3173Interpolated Year when operation took place | OperationsUKBB000003724.49
3174IDP dMRI ProbtrackX ICVF ml rGCST900043934.49
3175Percentage of FA2G1 in total neutral plasma glycans (GPn) (GP61)GCST906685054.48
3176ADAMTSL4 levelsGCST904682294.48
3177Phospholipid levels in medium VLDLGCST900929244.48
3178Pork consumptionGCST901329994.47
3179Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T305ECGA0003054.47
3180Abdominal aortic calcification levelsGCST901346144.47
3181Saturated fatty acids to total fatty acids percentageGCST905027004.47
3182PDLIM7/TBC1D23 ratioGCST903156404.47
3183Wears glasses or contact lenses | EyesightUKBB000009074.47
3184Cholelithiasis and cholecystitis | digestiveUKBB000001334.46
3185Cholesterol in Small HDLGCST904993584.46
3186ACY3 levelsGCST904682134.46
3187IGSF8 levelsGCST904695404.46
3188Mental and behavioural disorders due to use of other stimulants, including caffeineFING000008114.46
3189CD209/CLEC4G ratioGCST903137504.45
3190Cholesterol to total lipids in medium LDL percentage (UKB data field 23620)GCST902697174.45
3191wg rh intensity-contrast medialorbitofrontalGCST900038404.45
3192IDP dMRI TBSS ICVF Tapetum RGCST900043734.45
3193DKK3/LTBP2 ratioGCST903144874.45
3194Calcium levelsGCST900259904.44
3195CirrhosisGCST903198774.44
3196Lung volumeGCST900166684.44
3197Monounsaturated fatty acid levelsGCST905023594.43
3198Lymphocyte countGCST900023884.43
3199Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T224ECGA0002244.43
3200Platelet distribution widthGCST900024014.43
3201VLDL cholesterol levels (UKB data field 23403)GCST902695004.42
3202IDP dMRI ProbtrackX L2 cgc lGCST900042774.42
3203Omega-6 fatty acids to omega-3 fatty acids ratioGCST904991994.42
3204PPP1R2/TMSB10 ratioGCST903157214.42
3205T1 FreeSurfer a2009s lh S postcentral volumeGCST903848824.41
3206GFRA2/IL12A_IL12B ratioGCST903149254.41
3207Low hand grip strength (60 years and older) (EWGSOP)GCST900075274.41
3208Human herpes virus 7 U14 antibody levelsGCST900069094.41
3209Omega-6 fatty acid levelsGCST905025194.40
3210TTN levelsGCST904709844.40
3211BANK1/FOXO1 ratioGCST903134564.40
3212CA13/TYMP ratioGCST903135684.40
3213wg lh intensity-contrast paracentralGCST900038084.40
3214T1 CAT volume L CingulateGyrusanteriordivisionGCST903840564.40
3215EFNA1/PIK3IP1 ratioGCST903145984.40
3216IDP dMRI ProbtrackX ICVF fmaGCST900043854.40
3217Platelet count (UKB data field 30080)GCST904680954.40
3218NUDT16 levelsGCST904701054.40
3219CDH3/NECTIN4 ratioGCST903139524.39
3220IDP dMRI ProbtrackX ICVF str rGCST900043994.39
3221aparc-DKTatlas rh volume fusiformGCST900028984.39
3222Total Ceramide levelsGCST900258174.39
3223Phosphatidylethanolamine (38:4) levelsGCST904882614.39
3224APEX1/LSP1 ratioGCST903133074.38
3225LGALS9 levelsGCST904697654.37
3226AsthmaGCST900185754.37
3227CTSD/PRCP ratioGCST903143124.37
3228IDP dMRI ProbtrackX FA ifo lGCST900039374.37
3229Reason for reducing amount of alcohol drunk - Health precaution | AlcoholUKBB000007344.36
3230OXCT1 levelsGCST904701384.36
3231Triglycerides in IDL (UKB data field 23529)GCST902696264.36
3232Female infertility, cervigal, vaginal, other or unspecified originFING000005384.35
3233Skin color (cheek, B value)GCST905027794.35
3234ENO2/RWDD1 ratioGCST903146674.35
3235Emphysema (PheCode 496.1)GCST904760284.35
3236COL1A1/SOST ratioGCST903141724.35
3237Job involved shift work | Employment historyUKBB000003824.34
3238CYB5R2 levelsGCST904689374.34
3239Placental weight (fetal genotype, adjusted for sex and gestational age)GCST902751894.34
3240DNA methylation Hannum age accelerationGCST900142894.33
3241Omega-6 fatty acids to total fatty acids percentageGCST905021214.33
3242Cryptic phenotype that captures alpha-1-antitrypsin deficiency severityGCST901018254.33
3243EIF4B/IPCEF1 ratioGCST903146224.33
3244CCN2/DKK1 ratioGCST903137104.33
3245APOB/APOA1 ratioGCST900928104.33
3246IDP dMRI ProbtrackX FA ifo rGCST900039384.33
3247Diseases of external earFING000004244.32
3248REST UKBBICA NODEamps25 0001GCST903854844.32
3249IDP T1 FAST ROIs L cerebellum IXGCST900025844.31
3250FKBP1B/TGFB1 ratioGCST903148364.31
3251Erythematous conditions (PheCode 695)GCST904761774.31
3252CPA2/ITGB7 ratioGCST903142074.31
3253CD244/GP1BA ratioGCST903137664.31
3254Ratio of omega-6 fatty acids to total fatty acidsGCST900929354.30
3255wg lh intensity-contrast fusiformGCST900037984.30
3256TF levelsGCST904708414.30
3257Testicular dysfunction (PheCode 257)GCST904756964.29
3258STIP1/TMSB10 ratioGCST903158904.29
3259TNFSF12 levelsGCST904709194.29
3260GFER/MAVS ratioGCST903149194.29
3261LEPR/NTRK2 ratioGCST903153134.29
3262Alpha-hydroxyisovalerate levelsGCST901997364.28
3263PLEKHO1 levelsGCST904702564.28
3264Polyunsaturated fatty acids to saturated fatty acids ratioGCST905025964.28
3265CEP43/MPHOSPH8 ratioGCST903140194.27
3266Free Cholesterol in VLDLGCST905002174.27
3267SCG3 levelsGCST904705394.27
3268GoutFING000005874.26
3269HypertensionGCST900860914.26
3270Triglycerides to total lipids ratio in large LDLGCST900928674.26
3271Total diffusion tensor imaging along the perivascular space indexGCST904555464.26
3272IDP dMRI TBSS ICVF Genu of corpus callosumGCST900043294.25
3273LSP1/NADK ratioGCST903153314.25
3274platelet count (mean, inv-norm transformed)GCST904762994.25
3275AMBN levelsGCST904682874.25
3276Pure hypercholesterolaemiaFING000012304.25
3277Plasma lysine levels in chronic kidney diseaseGCST902654594.24
3278CPQ levelsGCST904688464.24
3279aseg global volume EstimatedTotalIntraCranialGCST900025974.24
3280Right-hemisphere dorsal attention network to amygdala white-matter structural connectivityGCST903028114.24
3281SIL1 levelsGCST904706384.24
3282RBP7 levelsGCST904704404.24
3283Plasma 3-hydroxyhexanoate levels in chronic kidney diseaseGCST902644984.23
3284rfMRI connectivity (ICA100 edge 383)GCST900052364.23
3285Cholesteryl esters in medium LDL (UKB data field 23541)GCST902696384.22
3286PLA2G4A/SNAP29 ratioGCST903156694.22
3287F-sodas liking (derived food-liking factor)GCST900948424.22
3288FLT3 levelsGCST904692514.22
3289X-21353 metabolite levelGCST906167084.22
3290Lung cancerGCST900186554.21
3291LAT levelsGCST904697414.21
3292Activities undertaken to treat anxiety | AnxietyUKBB000000094.21
3293Pain in limb (PheCode 773)GCST904762704.21
3294Reticulocyte countGCST900259724.20
3295PARP1/TCL1A ratioGCST903156024.20
3296SCPEP1 levelsGCST904705534.20
3297ADAM15 levelsGCST904682174.20
3298CCL19 levelsGCST904685714.20
3299Diseases of liverFING000004254.20
3300Mean volume of bilateral amygdalaGCST904749924.19
3301PEAR1/SCARF1 ratioGCST903156424.19
3302FLT3LG levelsGCST904692504.19
3303Amyotrophic lateral sclerosisGCST900271644.19
3304AIFM1/EGF ratioGCST903132194.18
3305Omega-3 fatty acids to total fatty acids percentageGCST905020814.18
3306T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 82)GCST903206454.18
3307ANGPTL4 levelsGCST904683054.18
3308Lymphocyte countGCST0046274.17
3309GBP1 levelsGCST904693114.17
3310TXNDC15 levelsGCST904709904.17
3311APP/BIN2 ratioGCST903133164.16
3312Chronic myeloproliferative diseaseFING000002944.16
3313CSF1/IL10RB ratioGCST903142844.16
3314CD22/SEMA7A ratioGCST903137594.15
3315Red cell distribution widthGCST900024044.15
3316CRADD/FKBP4 ratioGCST903142384.14
3317Age-related macular degenerationGCST900861114.14
3318IL5RA/TNFRSF13B ratioGCST903151644.14
3319Mean bone marrow fat fraction of lumbar vertebrae 1-5GCST906523914.13
3320Pain medicine use during menstruationGCST0066374.13
3321C1QL2 levelsGCST904684874.13
3322ACYP2 levelsGCST902401874.13
3323Free cholesterol to total lipids in very small VLDL percentage (UKB data field 23607)GCST902697044.13
3324VLDL cholesterol levelsGCST900929964.13
3325Mean platelet (thrombocyte) volume | Blood countUKBB000004504.13
3326SPARC levelsGCST904707184.12
3327Platelet distribution width | Blood countUKBB000006484.12
3328EDAR/SERPINB1 ratioGCST903145864.12
3329FLT4/ICAM2 ratioGCST903148604.12
3330CXCL6/DFFA ratioGCST903143574.12
3331GNS levelsGCST900884604.12
3332CLEC7A levelsGCST904687784.12
3333Basophil percentage of white cells varianceGCST905656884.12
3334CALCOCO1/VPS53 ratioGCST903136124.12
3335Carboplatin drug response (IC50)GCST900117834.11
3336ACY1/SCLY ratioGCST903131654.11
3337CST3/EFEMP1 ratioGCST903142924.11
3338NME3 levelsGCST904700554.11
3339BAG6/BMP6 ratioGCST903134504.10
3340PDLIM7/SRC ratioGCST903156394.10
3341C1QTNF9 levelsGCST904684914.09
3342Acetone levels (UKB data field 23477)GCST902695744.09
3343aseg rh volume VentralDCGCST900026444.09
3344TXN levelsGCST904709954.09
3345Heart failure with preserved EF [Diastolic heart failure] (PheCode 428.4)GCST904759844.09
3346Atherosclerosis, excluding cerebral and coronary sclerosisFING000001234.08
3347Operation code - squint correction | OperationsUKBB000005664.08
3348Phosphatidylcholine (40:8) levelsGCST900255384.08
3349Phospholipids in small VLDL (UKB data field 23511)GCST902696084.08
3350Pneumoconiosis due to other inorganic dustsFING000011734.08
3351Skin and soft tissue infectionsGCST900134114.08
3352CD300LF levelsGCST904686224.07
3353SERPINB1/SERPINB9 ratioGCST903158274.06
3354LCN2 levelsGCST904697474.06
3355DARS1/MAP4K5 ratioGCST903144044.06
3356CDH1/CDH17 ratioGCST903139454.06
3357EBAG9/TBCC ratioGCST903145684.06
3358Omega-6 fatty acids to total fatty acids percentageGCST905021274.05
3359IDP dMRI ProbtrackX OD slf rGCST900044724.05
3360LILRB4 levelsGCST904267084.05
3361ABHD14B/CRADD ratioGCST903131414.05
3362IGLC2 levelsGCST904695364.05
3363Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T222ECGA0002224.04
3364QDPR levelsGCST904704004.04
3365SFTPA2 levelsGCST904706134.04
3366WIF1 levelsGCST904710784.04
3367Tea difference likingGCST900948554.04
3368APP levelsGCST904683444.03
3369DOK2/PPP1R2 ratioGCST903145374.03
3370Lymphocyte count (UKB data field 30120)GCST904680824.02
3371HBEGF levelsGCST900120674.02
3372eGFR in diabetes mellitus (loose) (minimal adjustment)GCST906247834.02
3373Docosahexaenoic acid to total fatty acids percentageGCST905022804.02
3374GLOD4/S100A4 ratioGCST903149444.02
3375TNFSF12/TNFSF13 ratioGCST903159414.01
3376ABL1/PDLIM7 ratioGCST903131504.01
3377LAT2 levelsGCST904697394.01
3378FKBP4/RWDD1 ratioGCST903148404.01
3379PTPN6/YES1 ratioGCST903157504.01
3380PPCDC levelsGCST904702904.01
3381CLEC14A/TNFRSF21 ratioGCST903140824.01
3382Neutrophil percentage of white cells varianceGCST905657014.00
3383Bioavailable testosterone levelsGCST900121044.00
3384RAB10 levelsGCST904704034.00
3385CA3/HMBS ratioGCST903135844.00
3386Cholesterol to total lipids in medium VLDL percentage (UKB data field 23595)GCST902696924.00
3387Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)FING000008464.00
3388DAPK2 levelsGCST902408773.99
3389Rhodanobacter abundance in stoolGCST900325363.99
3390QC SWI-to-T1 linear alignment discrepancyGCST900063523.99
3391GSTA1/KRT18 ratioGCST903149933.99
3392Cholesteryl esters to total lipids in large VLDL percentage (UKB data field 23591)GCST902696883.99
3393Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T381ECGU0003813.98
3394RGS18 levelsGCST902426173.98
3395CALCOCO1/PDLIM7 ratioGCST903136073.98
3396BST2 levelsGCST904684753.97
3397RBP5 levelsGCST904704393.97
3398COL18A1/RETN ratioGCST903141703.97
3399EIF4G1/MAVS ratioGCST903146363.97
3400LPCAT2/SERPINB8 ratioGCST903153283.97
3401Phospholipid levels in small VLDLGCST900929763.96
3402FOLH1 levelsGCST904692583.96
3403ANPEP/CXADR ratioGCST903132723.96
3404Right-hemisphere somatomotor network to pallidum white-matter structural connectivityGCST903027973.95
3405ICAM2 levelsGCST904694993.95
3406Varicose veinsGCST900861443.95
3407Degree of unsaturationGCST905027533.95
3408aseg global volume CC-CentralGCST900026093.94
3409FASLG levelsGCST904691913.94
3410LCAT levelsGCST904697453.94
3411Saturated fatty acids levelsGCST905026713.93
3412Skin color (cheek, ITA value)GCST905027803.93
3413CRTAM/ICAM3 ratioGCST903142763.93
3414FLT3LG levelsGCST902747913.93
3415CD72 levelsGCST904686463.93
3416Metabolic disorder, other/unspecifiedFING000008153.93
3417Linoleic acid levelsGCST905022953.92
3418DAG1/DKK1 ratioGCST903143733.92
3419FYB1/PPP1R12A ratioGCST903149133.92
3420Multi-trait sex scoreGCST902701163.91
3421MAVS/SCAMP3 ratioGCST903153963.91
3422ACP5 levelsGCST904682033.91
3423Right-hemisphere visual network to caudate white-matter structural connectivityGCST903027823.91
3424SarcoidosisFING000012753.91
3425Ever sought or received professional help for mental distress | Mental distressUKBB000002223.91
3426Diacylglycerol_34:3_[M+H-H2O]1+ levelsGCST900601773.91
3427EFEMP1/IL18BP ratioGCST903145963.90
3428Fracture of forearmGCST902812733.90
3429Glucose levelsGCST900928193.90
3430Ceramide_40:1_[M-H]1- levelsGCST900601983.90
3431Illnesses of father - High blood pressure | Family historyUKBB000003433.90
3432IMPA1/TBCC ratioGCST903151753.90
3433MYOC/NOTCH3 ratioGCST903155073.90
3434Alkaline phosphatase (UKB data field 30610)GCST904680603.89
3435BACH1/DIABLO ratioGCST903134373.89
3436DTI TBSS L3 Posterior corona radiata RGCST903845503.89
3437Asphyxia and hypoxemia (PheCode 1013)GCST904755593.89
3438Recent feelings of inadequacy | DepressionUKBB000007393.88
3439Plasma sphingomyelin (d18:1/25:0, d19:0/24:1, d20:1/23:0, d19:1/24:0)* levels in chronic kidney diseaseGCST902659713.88
3440MUC2 levelsGCST904699653.88
3441Citrate levels (UKB data field 23473)GCST902695703.88
3442AK1/NSFL1C ratioGCST903132243.88
3443MENT levelsGCST904698863.88
3444VSTM2B levelsGCST904710563.88
3445HHEX levelsGCST904694513.87
3446ART3/GPC1 ratioGCST903133613.87
3447HEXIM1/NT5C3A ratioGCST903150483.87
3448CD40/CRELD2 ratioGCST903138113.87
3449GP6/LGALS8 ratioGCST903149643.87
3450aparc-Desikan rh area parsopercularisGCST900031243.87
3451PLSCR3 levelsGCST904702613.87
3452CD20 on IgD- CD27- B cellGCST900017543.87
3453Fluid intelligence score | Fluid intelligence / reasoningUKBB000002503.87
3454PAMR1/RARRES2 ratioGCST903155953.87
3455LAMA4 levelsGCST904697313.87
3456Nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [LDH] (PheCode 573.6)GCST904760943.86
3457PM20D1 levelsGCST904702683.86
3458ARNT levelsGCST904683673.86
3459BTN2A1/CSF1 ratioGCST903135413.86
3460Total Phosphatidylcholine levelsGCST900252043.86
3461FABP4/FGF21 ratioGCST903147583.85
3462IPCEF1/SERPINE1 ratioGCST903151843.85
3463QDPR/THOP1 ratioGCST903157573.85
3464DDC levelsGCST904689673.85
3465Cancer (UKB data field 2453)GCST900436283.84
3466HRC levelsGCST904694753.84
3467DECR1 levelsGCST904689783.83
3468ANGPT1/DKK1 ratioGCST903132633.83
3469platelet count (maximum, inv-norm transformed)GCST904762963.83
3470TMSB10/ZBTB16 ratioGCST903159263.81
3471TNFRSF6B levelsGCST904709143.81
3472ENAH levelsGCST904691063.81
3473NAAA/SMPD1 ratioGCST903155103.81
3474mean corpuscular hemoglobin concentration (MCHC, mean, inv-norm transformed)GCST904754583.81
3475VEGFC levelsGCST904710363.80
3476Seen a psychiatrist for nerves, anxiety, tension or depression | Mental healthUKBB000007643.80
3477Prescriptions - metformin | biguanides,diabetesUKBB000006923.80
3478Prescriptions - biguanides|diabetesUKBB000006713.80
3479GDF15 levelsGCST904693213.80
3480Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T107ECGU0001073.80
3481IDP dMRI TBSS ISOVF Anterior corona radiata LGCST900045003.80
3482IDP dMRI TBSS L3 Posterior limb of internal capsule RGCST900041893.79
3483Breakthrough COVID-19 susceptibility after at least one dose of a COVID-19 vaccineGCST904486953.79
3484VSIR levelsGCST904710533.79
3485Physical activity (Relative amplitude)GCST900614323.79
3486TOMM20 levelsGCST904709313.78
3487CLEC1B/EGF ratioGCST903140893.78
3488Valine levelsGCST902434533.78
3489AmygNuclei rh volume Accessory-Basal-nucleusGCST900026603.78
3490MGLL/STK4 ratioGCST903154433.77
3491Attention deficit hyperactivity disorderGCST905684413.77
3492OPTC levelsGCST904701283.77
3493Red cell distribution widthGCST0068043.77
3494Citrate levelsGCST902434423.76
3495DBI/EDAR ratioGCST903144083.76
3496IL3RA levelsGCST904695963.76
3497Educational attainmentGCST0034963.76
3498EDN1 levelsGCST904690733.76
3499DTI autoptx L2 str l tractGCST903851893.76
3500AmygNuclei rh volume Medial-nucleusGCST900026633.76
3501KHK levelsGCST904696753.76
3502PTPN1/TDRKH ratioGCST903157453.75
3503HSD11B1 levelsGCST904694823.75
3504Oral glucose tolerance test-0hGCST902977883.75
35051-stearoyl-2-arachidonoyl-GPI (18:0/20:4) levelsGCST901996493.74
3506Plasma cystathionine levels in chronic kidney diseaseGCST902649743.74
3507SUMF2 levelsGCST904707843.74
3508Abdominal aortic aneurysm (AAA)FING000000013.74
3509Bone marrow fat fraction of thoracic vertebra 10GCST906523823.74
3510Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T306ECGA0003063.73
3511Reason for glasses/contact lenses - For 'astigmatism' | EyesightUKBB000007333.73
3512Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T446ECGA0004463.73
3513Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T382ECGU0003823.72
3514IDP dMRI TBSS ICVF Posterior corona radiata LGCST900043543.72
3515CCL13/CCL8 ratioGCST903136763.72
3516Cholesteryl esters to total lipids ratio in very large VLDLGCST900930193.72
3517QC dMRI-to-T1 linear alignment discrepancyGCST900063513.71
3518eGFR in diabetes mellitus (full adjustment)GCST906247863.71
3519BIN2/PDLIM7 ratioGCST903135093.71
3520KLB levelsGCST904696933.71
3521Brainstem global volume MidbrainGCST900027673.71
3522ARHGAP30 levelsGCST904683543.71
3523Right ventricular peak atrial filling rateGCST902681193.71
3524Self-reported risk-taking behaviourGCST0068103.71
3525Polyunsaturated fatty acids to total fatty acids percentageGCST904992993.70
3526CTF1 levelsGCST904689013.70
3527IDP dMRI TBSS L2 Posterior thalamic radiation RGCST900041513.69
3528TNIP1 levelsGCST904709253.69
3529CLEC1B/RWDD1 ratioGCST903141023.69
3530CLEC1B/VTA1 ratioGCST903141073.69
3531MASP1 levelsGCST904698633.69
3532CD48/SLAMF7 ratioGCST903138423.68
3533T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 65)GCST903208843.68
3534CCL8 levelsGCST904223463.67
3535Vitamin D levelsGCST0053673.67
3536Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T437ECGA0004373.67
3537IDP T1 FAST ROIs L cerebellum VGCST900025643.67
3538Hip circumferenceGCST902786333.66
3539T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 6)GCST903205693.66
3540METAP1D/PLXNA4 ratioGCST903154273.66
3541Wears glasses or contact lenses (UKB data field 2207)GCST900428753.65
3542CCL4 levelsGCST0044333.65
3543SKAP2 levelsGCST904706463.65
3544Platelet countGCST900023583.65
3545SLC35G2 levelsGCST902428573.65
3546Total fatty acid levelsGCST905027233.65
3547Statin-associated type 2 diabetes mellitusGCST906525173.65
3548Phospholipids to total lipids ratio in medium VLDLGCST900929253.65
3549GDF2 levelsGCST904693223.64
3550Feeling fed-upGCST0069473.64
3551Calcium | Blood biochemistryUKBB000001143.64
3552Mean volume of bilateral amygdalaGCST904748993.64
3553STK11 levelsGCST904707653.64
3554ANGPTL2 levelsGCST904683033.64
3555Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T289ECGA0002893.64
3556Volume of right accessory basal nucleusGCST904750063.64
3557EGF/MANF ratioGCST903146093.64
3558Linoleic acid to total fatty acids percentageGCST905023363.63
3559CEBPB/NADK ratioGCST903140063.63
3560Sphingomyelins levels (UKB data field 23438)GCST902695353.63
3561BCAN/DPP6 ratioGCST903134783.62
3562FUT3 or FUT5 levelsGCST904692803.62
3563Basophil count varianceGCST905656823.62
3564Lysoalkylphosphatidylcholine (O-22:1) levelsGCST900241963.62
3565PMVK/RHOC ratioGCST903156973.62
3566Valine levelsGCST905001773.62
3567Sphingomyelin levelsGCST900929823.61
3568EPHA1 levelsGCST904691293.61
3569Glycated haemoglobin HbA1c levels (UKB data field 30750)GCST904680723.61
3570EDAR/ERBIN ratioGCST903145753.61
3571Cholesterol_[M+H-H2O]1+ levelsGCST900601333.61
3572EBAG9/EDAR ratioGCST903145633.61
3573Triglycerides to total lipids ratio in small LDLGCST900929673.60
3574DTI autoptx FA ptr l tractGCST903851313.60
3575Other disorders of skin and subcutaneous tissue, not elsewhere classifiedFING000010363.60
3576Gut bacterial pathway abundance (PYRIDNUCSYN.PWY..NAD.biosynthesis.I..from.aspartate.)GCST900276383.60
3577Ascites (non malignant) (PheCode 572)GCST904760903.60
3578Left-hemisphere visual network to right-hemisphere limbic network white-matter structural connectivityGCST903026593.60
3579Mandibular retrognathiaFING000007843.60
3580Non-cancer illness code, self-reported - hayfever/allergic rhinitis | Medical conditionsUKBB000005133.59
3581COX5B/GFER ratioGCST903142003.59
3582Ulcerative colitis (PheCode 555.2)GCST900441553.59
3583wg rh intensity-contrast rostralanteriorcingulateGCST900038523.58
35845-hydroxyindole sulfate levelsGCST902000503.58
3585IDP dMRI TBSS ICVF Anterior corona radiata RGCST900043493.58
3586aseg global volume BrainSegGCST900025903.58
3587THBD levelsGCST904708533.57
3588Kidney transplant statusFING000007103.57
3589Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T381ECGA0003813.57
3590Carcinoma in situ of breast, intraductal (controls excluding all cancers)FING000002403.57
3591IDP dMRI ProbtrackX OD slf lGCST900044713.57
3592Alcohol likingGCST900946883.56
3593DTI TBSS MD Anterior corona radiata LGCST903845953.56
3594PPM1B levelsGCST904702963.56
3595Autoimmune polyglandular failureFING000001353.56
3596Total lipids in medium VLDLGCST904989943.56
3597COL2A1 levelsGCST904688163.56
3598SEMA3G levelsGCST902427463.56
3599CA5A levelsGCST904685143.56
3600ESAM/SCARF1 ratioGCST903147153.56
3601Ever depressed for a whole week | Mental healthUKBB000002143.56
3602CKAP4/LAMP3 ratioGCST903140733.55
3603Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T382ECGA0003823.55
3604Other (seronegative) rheumatoid arthritis, wideFING000009173.55
3605C9 Carnitine levels in chronic kidney diseaseGCST902576823.55
3606ChronotypeGCST0038373.54
3607Free cholesterol levels in medium HDLGCST901326793.54
3608MITD1/SNX9 ratioGCST903154543.54
3609CEACAM8/PGLYRP1 ratioGCST903140033.54
3610CNTN5/ROBO2 ratioGCST903141663.54
3611CSTB levelsGCST904688983.53
3612MDK levelsGCST904698773.53
3613ALDH1A1/CA2 ratioGCST903132433.53
3614Female infertilityFING000005363.53
3615Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T380ECGA0003803.53
3616EPHB6/VWC2 ratioGCST903146833.53
3617PRKRA levelsGCST904703313.53
3618BMP10 levelsGCST904684523.52
3619IGFBP3 levelsGCST904695293.52
3620COL6A3/OGN ratioGCST903141773.52
3621Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T383ECGA0003833.52
3622aseg global volume BrainSegNotVentSurfGCST900025923.52
3623CLMP/TNFRSF19 ratioGCST903141363.52
3624RNASE3 levelsGCST904704773.52
3625CRELD2/F2R ratioGCST903142543.51
3626Liver enzyme levels (alkaline phosphatase)GCST900134063.51
3627IDP dMRI TBSS L2 Cingulum cingulate gyrus LGCST900041583.51
3628CD20 on IgD- CD24- B cellGCST900017533.51
3629Crohns diseaseGCST904681213.51
3630Total triglycerides levelsGCST0036643.51
36311-palmitoyl-2-arachidonoyl-gpc (16:0/20:4n6) levelsGCST902006923.51
3632BCR/PLXNA4 ratioGCST903134973.50
3633AHNAK2 levelsGCST904682603.50
3634IDP dMRI ProbtrackX ICVF str lGCST900043983.50
3635Platelet distribution widthGCST0046163.50
3636F-caffeinated/sweet liking (derived food-liking factor)GCST900947203.50
3637Diacylglycerol_36:1_[M+H-H2O]1+ levelsGCST900601933.49
3638Non-albumin protein levelsUKBB000005033.49
3639AMIGO2 levelsGCST904682923.49
3640Apple juice likingGCST900946903.49
3641SIRPB1 levelsGCST904706403.48
3642Ever unenthusiastic/disinterested for a whole week | Mental healthUKBB000002263.48
3643Red blood cell erythrocyte distribution width (UKB data field 30070)GCST904680993.48
3644PDGFB/USP8 ratioGCST903156333.48
3645METAP1D levelsGCST904698923.47
3646DBI/TMSB10 ratioGCST903144143.47
3647rfMRI amplitudes (ICA100 node 11)GCST900045993.47
3648Phosphatidylcholine_35:2_[M+H]1+/Phosphatidylethanolamine_38:2_[M+H]1+/Phosphatidate_40:3_[M+NH4]1+ levelsGCST900603253.47
3649IPCEF1/SMAD1 ratioGCST903151853.47
3650Total esterified cholesterol levels (UKB data field 23415)GCST902695123.47
3651SarcoidosisGCST900186983.47
3652APP/NID1 ratioGCST903133263.47
3653Cholesteryl esters in small LDL (UKB data field 23548)GCST902696453.46
3654Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T278ECGU0002783.46
3655Use of disulfiram, acamprosate or naltrexoneFING000014103.46
3656HEXIM1/TBL1X ratioGCST903150533.45
3657SMPD3 levelsGCST904706853.45
3658TNFSF13B levelsGCST904709203.45
3659Bone marrow fat fraction of lumbar vertebra 3GCST906523883.45
3660AGRP/CCN1 ratioGCST903132023.45
3661Testosterone levels (UKB data field 30850)GCST904681033.45
3662Calcium levels (UKB data field 30680)GCST904680653.45
3663Excessive sweatingGCST0060903.45
3664CXCL11/DKK1 ratioGCST903143343.44
3665Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T386ECGA0003863.44
3666wg lh intensity-contrast rostralanteriorcingulateGCST900038173.44
3667GOPC/IRAK4 ratioGCST903149543.44
3668MGLL/MITD1 ratioGCST903154363.44
3669Mean corpuscular hemoglobinGCST900187443.43
3670Omega-6 fatty acids to total fatty acids percentageGCST905025293.43
3671DAB2/GRAP2 ratioGCST903143643.43
3672Coriander likingGCST900947443.43
3673IDP dMRI TBSS ICVF Superior corona radiata RGCST900043513.43
3674Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T387ECGA0003873.43
3675EDAR/TMSB10 ratioGCST903145903.42
3676T1 FreeSurfer DKT rh lingual areaGCST903842973.42
3677DKK1 levelsGCST904689973.42
3678PGLYRP1 levelsGCST904702193.41
3679MS-disease / Multiple SclerosisFING000008393.41
3680aseg rh number HolesBeforeFixingGCST900026473.41
3681Phosphate | Blood biochemistryUKBB000006443.40
3682STX8 levelsGCST904707763.40
3683Father's age at death | Family historyUKBB000002413.40
3684C3 levelsGCST902810413.40
3685Heel quantitative ultrasound index (QUI), direct entry (right) | Bone-densitometry of heelUKBB000003233.40
3686Heel bone mineral density (BMD) T-score, automated (right) | Bone-densitometry of heelUKBB000003173.39
3687Medication use (glucocorticoids)GCST900187803.39
3688Influenza and pneumoniaFING000006793.39
3689Free cholesterol in medium VLDL (UKB data field 23507)GCST902696043.39
3690Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T385ECGU0003853.39
3691Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T219ECGA0002193.39
3692Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T380ECGU0003803.38
3693Abnormality of gait (PheCode 350.2)GCST904758413.38
3694IGFBP6/PTGDS ratioGCST903151373.37
3695Cholesterol to total lipids in chylomicrons and extremely large VLDL percentage (UKB data field 23580)GCST902696773.37
3696Placental weight (fetal genotype, adjusted for sex)GCST902751973.37
3697Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T304ECGA0003043.36
3698DTI autoptx L3 ptr l tractGCST903852123.36
3699IDP dMRI ProbtrackX ICVF slf rGCST900043973.36
3700CDKN1A/TACC3 ratioGCST903139753.35
3701Hypertrophy of breastFING000006443.35
3702CD55/ITGB1 ratioGCST903138463.35
3703DTI autoptx MD fmi tractGCST903852313.35
3704Crohn's disease NASFING000003673.35
3705Placental weight (paternal genotype, adjusted for sex)GCST902751993.35
3706Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T294ECGU0002943.35
3707Percentage of FA2G1 in total neutral plasma glycans (GPn) (GP61)GCST906687393.34
3708CD84/DKK1 ratioGCST903139113.34
3709Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T284ECGA0002843.34
3710F7 levelsGCST904691713.34
3711PLXNB3/SNAP23 ratioGCST903156933.34
3712EDAR/F11R ratioGCST903145763.34
3713Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T384ECGU0003843.34
3714Ratio of polyunsaturated fatty acids to total fatty acidsGCST900929413.34
3715KIR2DL3 levelsGCST904696853.33
3716BPIFA2 levelsGCST904684613.33
3717DAG1/DBNL ratioGCST903143723.33
3718Two-hour glucoseGCST900022273.33
3719TNFRSF8 levelsGCST904709153.33
3720GPD1 levelsGCST904693883.33
3721SnoringGCST0097623.32
3722Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T429ECGU0004293.32
3723CAPG levelsGCST904685373.32
3724Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T445ECGA0004453.32
3725Bone marrow fat fraction of lumbar vertebra 4GCST906523893.32
3726ITGA2 levelsGCST904696343.32
3727Free cholesterol in very large VLDLGCST905005813.32
3728Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T383ECGU0003833.31
3729red cell diameter width (RDW, mean, inv-norm transformed)GCST904763613.31
3730ANGPTL3 levelsGCST904683043.31
3731EmphysemaFING000004963.31
3732Total cholesterol levels in HDLGCST901326813.31
3733Anterior diffusion tensor imaging along the perivascular space indexGCST904555433.31
3734DTI TBSS L3 Superior cerebellar peduncle RGCST903845363.31
3735CST3/TIMP1 ratioGCST903143003.31
3736Platelet countGCST900187493.30
3737Modified Stumvoll Insulin Sensitivity Index (model adjusted for BMI)GCST0036583.30
3738Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T105ECGU0001053.30
3739Urine glycocholenate sulfate* levels in chronic kidney diseaseGCST902652923.30
3740T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 24)GCST903205873.30
3741LGALS3 levelsGCST900120093.29
3742CRELD2/NUCB2 ratioGCST903142563.29
3743PPME1/PSMD9 ratioGCST903157053.29
3744Osteoporosis, osteopenia and pathological fracture (PheCode 743)GCST904762583.29
3745Hands-free device/speakerphone use with mobile phone in last 3 month | Electronic device useUKBB000003043.29
3746BTN2A1/IFNGR1 ratioGCST903135433.28
3747wg lh intensity-contrast entorhinalGCST900037973.28
3748Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T303ECGU0003033.28
3749Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T378ECGU0003783.28
3750Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T379ECGU0003793.28
3751PBLD levelsGCST904701633.28
3752Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T384ECGA0003843.28
3753GALNT10/IGSF3 ratioGCST903149143.28
3754Cholesteryl ester levels in small LDLGCST900929583.27
3755CXCL5 levelsGCST904689323.27
3756X-11444 metabolite levelGCST906165453.27
3757Mean platelet volume during second trimester of pregnancyGCST903022303.27
3758CEACAM5 levelsGCST904686963.27
3759Volume of right medial nucleusGCST904749253.27
3760GCNT1 levelsGCST904693193.26
3761NOTCH1/TIE1 ratioGCST903155463.26
3762Ulcerative colitisGCST0041333.26
3763HHIP levelsGCST906170973.26
3764Mean diameter of VLDL particlesGCST901327343.26
3765Total cholesterol levels (UKB data field 23400)GCST902694973.26
3766Red cell distribution widthGCST0046213.25
3767QC rfMRI cleaned inverse tSNRGCST900063583.25
3768Cystatin C productionGCST902679863.25
3769Degeneration of macula and posterior pole of retina (PheCode 362.2)GCST904758493.25
3770Basophil countGCST900187263.25
3771SH2B3 levelsGCST904706163.24
3772IDP dMRI TBSS FA Retrolenticular part of internal capsule LGCST900038983.24
3773Fracture of radius and ulna (PheCode 803.2)GCST904762803.24
3774IL6ST levelsGCST904696033.23
3775GIMAP7 levelsGCST904693453.23
3776Platelet count during third trimester of pregnancyGCST903022263.23
3777DNAJB14 levelsGCST902409523.23
3778Degree of unsaturationGCST905027343.23
3779LONP1 levelsGCST904697853.23
3780IDP dMRI TBSS L1 Sagittal stratum LGCST900041063.22
3781ENG levelsGCST904691083.22
3782PLXDC2 levelsGCST904702643.22
3783Systemic connective tissue disordersFING000013503.22
3784FGF23 levelsGCST904692233.21
3785CD101 levelsGCST904685963.21
3786C20:4 Lysophosphatidylcholine levels in chronic kidney diseaseGCST902575703.21
3787PSMD9/UBAC1 ratioGCST903157353.21
3788Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T385ECGA0003853.21
3789MTSS2 levelsGCST904699613.20
3790Cholesteryl esters to total lipids in chylomicrons and extremely large VLDL percentage (UKB data field 23581)GCST902696783.20
3791Phosphate levels (UKB data field 30810)GCST904680943.19
3792CD36 levelsGCST904686273.19
3793CLSTN3 levelsGCST904687903.19
3794Other eye problems | EyesightUKBB000006103.19
3795IDP dMRI ProbtrackX L3 ifo lGCST900043123.19
3796DTI TBSS MO Middle cerebellar peduncleGCST903846203.19
3797IDP dMRI ProbtrackX ISOVF ifo lGCST900045373.18
3798Hemangioma of skin and subcutaneous tissue (PheCode 228.1)GCST904756333.18
3799EIF4G1/PLA2G4A ratioGCST903146383.18
3800MIA levelsGCST904699033.18
3801Hypertrophic scarFING000006423.18
3802ErysipelasFING000005183.17
3803Synonym | Fluid intelligence / reasoningUKBB000008023.17
3804wg rh intensity-contrast parstriangularisGCST900038463.17
3805IL2RA/NCR1 ratioGCST903151613.17
3806T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 102)GCST903209213.17
3807CALCOCO1/PFKFB2 ratioGCST903136083.17
3808Excessive hairinessGCST0060953.17
3809Urine methylsuccinoylcarnitine levels in chronic kidney diseaseGCST902655093.17
3810UGDH levelsGCST904710063.17
3811Ulcerative colitisGCST904753223.17
3812IDP dMRI ProbtrackX ISOVF cgc lGCST900045293.16
3813NFU1 levelsGCST904700403.16
3814CTSF/NAAA ratioGCST903143143.16
3815IDP dMRI ProbtrackX L1 cgc lGCST900042503.16
3816F-sweetened coffee drink liking (derived food-liking factor)GCST900948533.16
3817Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T102ECGU0001023.16
3818IDP dMRI ProbtrackX MD cst lGCST900042273.16
3819Multiple myelomaGCST906247473.16
3820TNR levelsGCST904709293.16
3821Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T379ECGA0003793.16
3822DNAJB1/STIP1 ratioGCST903145133.15
3823ACVRL1/EFNA4 ratioGCST903131563.15
3824DKK1/PDGFA ratioGCST903144753.15
3825Frequency of heavy DIY in last 4 weeks | Physical activityUKBB000002633.14
3826Plasma betaine levels in chronic kidney diseaseGCST902648583.14
3827PATE4 levelsGCST902424053.14
3828Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T447ECGA0004473.14
3829Nonalcoholic fatty liver diseaseGCST900910333.13
3830PTPRK levelsGCST904703833.13
3831Congestive heart failure (CHF) NOS (PheCode 428.1)GCST904759823.13
3832aparc-DKTatlas lh volume caudalmiddlefrontalGCST900028643.13
3833Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T386ECGU0003863.13
3834EFNA4/VWC2 ratioGCST903146073.13
3835Androsterone sulfate levelsGCST902006743.12
3836PLA2G4A/SNX9 ratioGCST903156703.12
3837Smoking and associated risk behaviours (confirmatory factor analysis Factor 6)GCST903093413.12
3838CCL28 levelsGCST904685803.12
3839CD209/CLEC14A ratioGCST903137493.12
3840Triglycerides to total lipids in medium VLDL percentage (UKB data field 23598)GCST902696953.12
3841X-12707 levelsGCST902005023.11
3842DCTN1/ERBIN ratioGCST903144293.11
3843CPXM1/DKK1 ratioGCST903142183.11
3844Suppurative and unspecified otitis mediaFING000013463.11
3845T1 FreeSurfer BA lh BA2 exvivo volumeGCST903855343.10
3846Right-hemisphere salience/ventral attention network to pallidum white-matter structural connectivityGCST903028203.10
3847aparc-Desikan lh volume caudalmiddlefrontalGCST900027713.10
3848VASH1 levelsGCST904710263.10
3849aparc-Desikan lh volume parsopercularisGCST900027853.10
3850HypertensionGCST900860923.10
3851IDP T1 FAST ROIs R front operc cortexGCST900025323.09
3852CCL4 levelsGCST902747703.09
3853N-acetylglycine levelsGCST902435613.09
3854PRSS53 levelsGCST904703443.09
3855Red cell distribution widthGCST900259883.09
3856RETN levelsGCST904704573.09
3857Spicy food likingGCST900948463.09
3858S100A12 levelsGCST904705133.09
3859MTIF3 levelsGCST904699573.09
3860MYBPC1 levelsGCST904699693.09
3861DIABLO/GRAP2 ratioGCST903144663.08
3862Red blood cell (erythrocyte) distribution width | Blood countUKBB000007483.08
3863NUCB2/RSPO3 ratioGCST903155753.08
3864IDP dMRI TBSS FA Anterior corona radiata RGCST900038993.08
3865Lysoalkylphosphatidylcholine (O-24:0) levelsGCST900248123.07
3866Hemoglobin A1c levelsGCST900187383.07
3867Macular degenerationGCST904753863.07
3868Triglyceride levels in very small VLDLGCST901326693.07
3869Other specified disorders of external earFING000011043.07
3870Triglycerides to total lipids in IDL percentage (UKB data field 23613)GCST902697103.07
3871Heel bone mineral density (BMD) (right) | Bone-densitometry of heelUKBB000003143.06
3872CD244 levelsGCST904686113.06
3873ABL1 levelsGCST904681903.06
3874RCC1 levelsGCST904704433.06
3875Fluid intelligence score (baseline)GCST905658423.06
3876VEGFA levelsGCST904710343.06
3877Ratio of bis-allylic bonds to double bonds in lipidsGCST901327443.05
3878CDKN1A/FXN ratioGCST903139713.05
3879CD46/SIAE ratioGCST903138353.05
3880MMP8/TGFA ratioGCST903154663.05
3881Endometriosis of rectovaginal septum and vaginaFING000005033.05
3882CTSV levelsGCST904689173.04
3883ERBB4/NELL1 ratioGCST903146913.04
3884ALB levelsGCST900187253.04
3885X-11550 levelsGCST902436483.04
3886CD302/IL12A_IL12B ratioGCST903138063.03
3887DTI TBSS MD Posterior corona radiata RGCST903845983.03
3888LAP3 levelsGCST904697373.03
3889Lysoalkylphosphatidylcholine (O-24:1) levelsGCST900241983.03
3890FGF5 levelsGCST904692263.03
3891IL1RL1 levelsGCST904695743.03
3892Degree of unsaturationGCST905027363.03
3893PENK levelsGCST904702083.03
3894CRADD/EDAR ratioGCST903142353.03
3895CNTN1/EGFR ratioGCST903141623.03
3896ADAMTS15/CLMP ratioGCST903131703.02
3897Umbilical hernia (PheCode 550.4)GCST904760623.02
3898REG1A/TFF3 ratioGCST903157643.02
3899Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T304ECGU0003043.01
3900CHGB levelsGCST904687423.01
3901lymphocyte (absolute count, mean, inv-norm transformed)GCST904754263.01
3902SELE levelsGCST904705663.01
39033-methyl-2-oxobutyrate levelsGCST901996773.01
3904First line medication for Crohn's diseaseFING000005443.01
3905KLK13 levelsGCST904696993.01
3906Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T378ECGA0003783.01
3907Sphingomyelin (d18:1/16:0) levelsGCST900257443.01
3908Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T288ECGA0002883.00
3909NUCB2 levelsGCST904701013.00
3910TIMM10 levelsGCST904708673.00
3911Other/unspecified dorsalgiaFING000011243.00
3912ARHGEF1 levelsGCST904683592.99
3913MATN2/SCARA5 ratioGCST903153882.99
3914Pregnenetriol disulfate levelsGCST902002382.99
3915Degree of unsaturationGCST905022242.99
3916ENG/TNFRSF10C ratioGCST903146502.99
3917Reticulocyte countGCST900024052.98
3918RARRES2/TFPI ratioGCST903157602.98
3919AmygNuclei lh volume Cortical-nucleusGCST900026542.98
3920CD40LG/MPIG6B ratioGCST903138252.98
3921XCL1 levelsGCST904710812.98
3922FYB1 levelsGCST904692842.97
3923BIN2/TMSB10 ratioGCST903135152.97
3924T1 FreeSurfer a2009s rh S collat transv ant areaGCST903849392.97
3925Enthesopathy (PheCode 726.1)GCST904762392.97
3926DLL1/EFEMP1 ratioGCST903144942.97
3927Operative procedures - Anastomosis of mammary artery to left anterior descending coronary artery | Summary OperationsUKBB000005712.96
3928Bioavailable testosterone levelsGCST900121032.96
3929Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T293ECGU0002932.96
3930Oily fish intake | DietUKBB000005472.96
3931Concentration of VLDL particlesGCST905002502.96
3932A1BG levelsGCST904681852.95
3933IDP dMRI TBSS ICVF Cingulum hippocampus RGCST900043632.95
3934Total lipids in medium LDL (UKB data field 23538)GCST902696352.95
3935Cholesteryl Esters in Medium VLDLGCST904989282.95
3936F-coffee/alcohol liking (derived food-liking factor)GCST900947372.94
3937rfMRI connectivity (ICA100 edge 1090)GCST900059432.94
3938Leucine levelsGCST902434052.94
3939Mosaic chromosomal alteration of the Y chromosomeGCST901652892.94
3940PF4 levelsGCST904702112.94
3941Osteopenia or other disorder of bone and cartilage (PheCode 743.9)GCST904762612.93
3942Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T376ECGA0003762.93
3943Testosterone levelsGCST904834872.93
3944Other non-toxic goitre | Disorders of thyroid glandUKBB000006172.93
3945IDP dMRI ProbtrackX FA fmiGCST900039362.93
3946IDP dMRI ProbtrackX FA cst rGCST900039342.93
3947CLPS/PLA2G1B ratioGCST903141402.93
3948Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T438ECGA0004382.93
3949End-diastolic bi-ventricular shape (principal component 10)GCST904484892.92
3950PLXNA4/USP8 ratioGCST903156902.92
3951ABO levelsGCST904681912.92
3952Benign neoplasm of skin (PheCode 216)GCST904756202.92
3953T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 41)GCST903208602.92
3954Congenital iodine-deficiency syndrome/hypothyroidismFING000003282.92
3955Familial combined hyperlipidemia defined by Dutch criteriaGCST901040052.92
3956CD46/TNFRSF14 ratioGCST903138382.92
3957CASP8/RILP ratioGCST903136572.92
3958CHRDL2 levelsGCST904687512.92
3959Multiple myeloma and malignant plasma cell neoplasms (controls excluding all cancers)FING000008432.92
3960Mean platelet volume during third trimester of pregnancyGCST903022312.91
3961IDP dMRI ProbtrackX FA ptr lGCST900039442.91
3962NECTIN2/SDC1 ratioGCST903155292.91
3963PRTN3/RETN ratioGCST903157342.91
3964BMP7 levelsGCST900881572.91
3965SLMAP levelsGCST904706732.91
3966IGFBP4/OGN ratioGCST903151342.91
3967SPARCL1 levelsGCST904707172.90
3968IDP dMRI TBSS ICVF Fornix cres+Stria terminalis RGCST900043652.90
3969SFRP1 levelsGCST904706102.90
3970PRRT3 levelsGCST904703402.90
3971Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T436ECGA0004362.90
3972T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 106)GCST903209252.90
3973Omega-6 fatty acids to total fatty acids percentageGCST905025412.90
3974Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T317ECGU0003172.90
3975LYPD3 levelsGCST904698282.89
3976HBEGF/PDGFB ratioGCST903150342.89
3977Adhesive capsulitis of shoulderFING000000432.89
3978CSF3R levelsGCST904688852.89
3979DyslipidemiaGCST900860772.89
3980Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T375ECGA0003752.89
3981Citrate levelsGCST900928132.89
3982LAT/MANF ratioGCST903152842.88
3983Porridge likingGCST900948152.88
3984LBR levelsGCST904697442.88
3985Polyunsaturated fatty acids to total fatty acids percentageGCST905026322.88
3986Other and unspecified nerve root and plexus disorders, also in other diseasesFING000009442.88
3987Metabolic syndromeGCST904444872.88
3988Cardiorespiratory fitness (vo2 max)GCST900933172.88
3989Cholesteryl ester levels in medium LDLGCST900929062.88
3990Frozen shoulderGCST900005132.88
3991MOG/RTBDN ratioGCST903154762.87
3992Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T305ECGU0003052.87
3993TNFRSF14/TNFRSF1A ratioGCST903159352.87
3994aseg global volume CC-AnteriorGCST900026112.87
3995LIFR levelsGCST904697692.87
3996End-diastolic bi-ventricular shape (principal component 1)GCST904484802.87
3997IDP dMRI ProbtrackX ICVF cst lGCST900043832.86
3998Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T289ECGU0002892.86
3999LY9 levelsGCST904698242.86
4000DNMBP/WWP2 ratioGCST903145222.86